Risk of tuberculosis in pregnancy: a national, primary care-based cohort and self-controlled case series study.
Dominik Zenner, Michelle E Kruijshaar, Nick Andrews...
https://pubmed.ncbi.nlm.nih.gov/22161161/Actively Recruiting
Led by Lund University · Updated on 2026-09-03
500
Participants Needed
1
Research Sites
52 weeks
Total Duration
This research investigates how tuberculosis TB infection affects the development and function of the placenta during pregnancy. It focuses on whether TB infection changes the structure or function of the placenta and if these changes contribute to pregnancy-related complications. The study is observational and includes pregnant women attending delivery clinics in Addis Abeba, Ethiopia, to better understand the impact of TB on maternal and infant health. Participants will be classified based on TB infection status using a blood-based interferon-gamma release assay QuantiFERON. The study involves collecting placental tissue after delivery for detailed examination, including histopathology, RNA and protein expression studies, and detection of TB bacteria. Blood samples and cord blood will also be collected for immune response and antibody analyses. Women with suspected active TB will undergo further diagnostic tests, including sputum sampling and chest X-rays. During the study, participants will provide information through electronic questionnaires about their medical and obstetric history. Physical assessments of mothers and infants will take place at birth and six weeks later. Placental samples will be processed and analyzed to identify pathological changes and molecular markers related to TB infection. The primary outcome is the presence of pathological placental findings, with secondary outcomes including placental gene and protein expression patterns and infant health outcomes. Participants will be followed up at six weeks postpartum for further evaluation and communication of test results.
CONDITIONS
Effects of Tuberculosis Infection on Development and Function of the Placenta
P
Per Bjorkman, MD, PhD
S
Selam Ghebrechristos, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Lund University
Lead Sponsor
Addis Ababa University
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - From delivery until 6 weeks postpartum
Participants provide medical and pregnancy history information and blood samples at delivery. Placental tissue is collected after birth for detailed examination. Follow-up assessments occur at six weeks postpartum including communication of test results.
1 visit at delivery and 1 follow-up visit at 6 weeks postpartum
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Have more questions? Get in touch with our team for quick support
Dominik Zenner, Michelle E Kruijshaar, Nick Andrews...
https://pubmed.ncbi.nlm.nih.gov/22161161/Offer Erez, Roberto Romero, Eunjung Jung...
https://pubmed.ncbi.nlm.nih.gov/35177220/Fregenet Tesfaye, John Walles, Erik Sturegård...
https://pubmed.ncbi.nlm.nih.gov/34319803/J E Myers, L Myatt, J M Roberts...
https://pubmed.ncbi.nlm.nih.gov/29978556/Senait Ashenafi, Getachew Aderaye, Martha Zewdie...
https://pubmed.ncbi.nlm.nih.gov/22923457/T Yee Khong, Eoghan E Mooney, Ilana Ariel...
https://pubmed.ncbi.nlm.nih.gov/27223167/Jyoti S Mathad, Sharan Yadav, Arthi Vaidyanathan...
https://pubmed.ncbi.nlm.nih.gov/36558815/Shilpa Naik, Mallika Alexander, Pavan Kumar...
https://pubmed.ncbi.nlm.nih.gov/33584652/John Walles, Niclas Winqvist, Stefan R Hansson...
https://pubmed.ncbi.nlm.nih.gov/37572363/Jerker Jonsson, Sharon Kühlmann-Berenzon, Ingela Berggren...
https://pubmed.ncbi.nlm.nih.gov/31862768/Lund University
Lead Sponsor
Addis Ababa University
Collaborating Sponsor